A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO1 ...
Case study with first patient images of half-life engineered MP0712 from compassionate care use show specific uptake in primary tumors and ...
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX) a clinical-stage oncology company focused on keeping cancer patients alive and helping them thrive, today reported ...
Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds ...
Operator: Ladies and gentlemen, thank you for joining us today. And third quarter 2025 results conference call. At this time, ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.
Stifel 2025 Healthcare Conference November 12, 2025 4:40 PM ESTCompany ParticipantsRachel McMinn - Founder, Executive Chair ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections ...
STATEN ISLAND, N.Y., Nov. 12, 2025 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback